The short version
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dobutamine
dobutamine · DOBUTAMINE HYDROCHLORIDE 250 mg/20mL · Injection · Intravenous · Slate Run Pharmaceuticals
NDC 70436-0203-80 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$11.99
Reported to Texas DSHS · 2025 annual filing · Slate Run Pharmaceuticals, LLC.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 250 MG
$7.691
HCPCS J1250 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$912
23 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA216131
- TE code
- AP
- Approval date
- Dec 21, 2022
- Patents / exclusivity
- None on file
Shortage history
- In shortage now — Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)Nov 6, 2017month 106 — 5× the typical 20-month injectable shortage
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of dobutamine (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Slate Run Pharmaceuticals | DOBUTAMINE HYDROCHLORIDE 250 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Dobutamine — NDC 70436-0203-80," retrieved September 3, 2026, https://drugdashboards.com/drug/70436020380.
Free to cite with attribution — see how the data is put together.